Books on the topic 'Blood-borne viruses'

To see the other types of publications on this topic, follow the link: Blood-borne viruses.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 42 books for your research on the topic 'Blood-borne viruses.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Mayfield, Eleanor. Protecting patients and professionals from blood-borne disease. [Rockville, Md.] (5600 Fishers Lane, Rockville 20857): [Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mayfield, Eleanor. Protecting patients and professionals from blood-borne disease. [Rockville, Md.] (5600 Fishers Lane, Rockville 20857): [Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Australia. Dept. of Health and Family Services. Blood borne viruses: Dental services project : final report. Canberra, A.C.T: Commonwealth Dept. of Health & Family Services, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Health, Great Britain Department of. Children in need and blood-borne viruses: HIV and hepatitis. London: Department of Health, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Association, British Dental. Guide to blood borne viruses and the control of cross infection in dentistry. London: British Dental Association, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Association, British Dental. Guide to blood borne viruses and the control of cross infection in dentistry: British Dental Association. London: British Dental Association[BDA], 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Great Britain. Department of Health. Health clearance for serious communicable diseases: New health care workers : draft guidance for consultation. London: Department of Health Publications, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

AIDS, Expert Advisory Group on. Guidance for clinical health care workers: Protection against infection with blood-borne viruses : recommendations of the Expert Advisory Group on AIDS and the Advisory Group on Hepatitis. [London]: Department of Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

United States. Congress. House. Committee on Education and Labor. Subcommittee on Health and Safety. Oversight hearings on OSHA's proposed standard to protect health care workers against blood-borne pathogens including the AIDS and hepatitis B viruses: Hearings before the Subcommittee on Health and Safety of the Committee on Education and Labor, House of Representatives, One Hundred First Congress, first session .... Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

United States. Congress. House. Committee on Education and Labor. Subcommittee on Health and Safety. Oversight hearings on OSHA's proposed standard to protect health care workers against blood-borne pathogens including the AIDS and hepatitis B viruses: Hearings before the Subcommittee on Health and Safety of the Committee on Education and Labor, House of Representatives, One Hundred First Congress, first session. Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

United States. Congress. House. Committee on Education and Labor. Subcommittee on Health and Safety. Oversight hearings on OSHA's proposed standard to protect health care workers against blood-borne pathogens including the AIDS and hepatitis B viruses: Hearings before the Subcommittee on Health and Safety of the Committee on Education and Labor, House of Representatives, One Hundred First Congress, first session. Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Association, British Orthopaedic. Guidelines for the prevention of cross-infection between patients and staff in orthopaedic operatingtheatres with special reference to HIV and the blood-borne hepatatis viruses: A guide prepared by a Working Party of the British Orthopaedic Association. [London]: British Orthopaedic Association, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Police and Blood-Borne Viruses. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Correctional Officers and Blood-Borne Viruses. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Emergency Services Providers and Blood-Borne Viruses. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Emergency Service Providers and Blood-borne Viruses. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Washington (State). Governor's Council on Substance Abuse., Washington (State). Governor's Advisory Council on HIV/AIDS., and Washington (State). Dept. of Health., eds. Prevention of blood-borne infections: Report. [Olympia, Wash: Washington State Dept. of Health, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Virginia, Almeida, Washington (State). Governor's Council on Substance Abuse., Washington (State). Governor's Advisory Council on HIV/AIDS., and Washington (State). Dept. of Health., eds. Prevention of blood-borne infections: Report. [Olympia, Wash: Washington State Dept. of Health, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Blood-Borne Viruses: A Resource for Professional Interpreters and Translators. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Great Britain. Department of Health., ed. Children in need and blood-borne viruses: HIV and hepatitis. London: Department of Health, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Blood-borne Viruses in the Workplace: Guidance for Employers and Employees. Health and Safety Executive (HSE), 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Aboriginal and Torres Strait Islander Health Workers and Blood-Borne Viruses. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Blood-Borne Viruses and Sexually Transmissable Infections: Illawarra Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Blood-Borne Viruses and Sexually Transmissable Infections: Murrumbidgee Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Blood-Borne Viruses and Sexually Transmissable Infections: Inner West Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Blood-Borne Viruses and Sexually Transmissable Infections: Southern NSW Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Blood-Borne Viruses and Sexually Transmissible Infections Western Sydney Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Blood-Borne Viruses and Sexually Transmissable Infections: New England Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Blood-Borne Viruses and Sexually Transmissable Infections: Nepean Blue Mountains Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Blood-Borne Viruses and Sexually Transmissable Infections: Far West Local Health District Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Blood-Borne Viruses and Sexually Transmissable Infections: South Western Sydney Medicare Local Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Blood-Borne Viruses and Sexually Transmissable Infections: Western NSW Local Health District Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Blood-Borne Viruses and Sexually Transmissable Infections: Mid-North Coast Local Health District Burden and Need. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Great Britain. Department of Health., ed. Hepatitis C infected health care workers: [implementing "Getting ahead of the curve: action on blood-borne viruses"]. London: DOH, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Smedley, Julia, Finlay Dick, and Steven Sadhra. Occupational infections. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199651627.003.0006.

Full text
Abstract:
Blood-borne viruses 150Hepatitis B 152Hepatitis C 154Human immunodeficiency virus 156Viral haemorrhagic fevers 158Variant Creutzfeldt–Jakob disease 160Bovine spongiform encephalopathy 162Meningococcal infection 164Tuberculosis 166Legionnaires’ disease 168Tetanus 170Severe acute respiratory syndrome 172Influenza 174Anthrax 176Glanders ...
APA, Harvard, Vancouver, ISO, and other styles
36

1965-, Southgate Erica, and Australian National Council on Drugs., eds. Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Canberra: Australian National Council on Drugs, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Vaheri, Antti, James N. Mills, Christina F. Spiropoulou, and Brian Hjelle. Hantaviruses. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198570028.003.0035.

Full text
Abstract:
Hantaviruses (genus Hantavirus, family Bunyaviridae) are rodent- and insectivore-borne zoonotic viruses. Several hantaviruses are human pathogens, some with 10-35% mortality, and cause two diseases: hemorrhagic fever with renal syndrome (HFRS) in Eurasia, and hantavirus cardiopulmonary syndrome (HCPS) in the Americas. Hantaviruses are enveloped and have a three-segmented, single-stranded, negative-sense RNA genome. The L gene encodes an RNA-dependent RNA polymerase, the M gene encodes two glycoproteins (Gn and Gc), and the S gene encodes a nucleocapsid protein. In addition, the S genes of some hantaviruses have an NSs open reading frame that can act as an interferon antagonist. Similarities between phylogenies have suggested ancient codivergence of the viruses and their hosts to many authors, but increasing evidence for frequent, recent host switching and local adaptation has led to questioning of this model. Infected rodents establish persistent infections with little or no effect on the host. Humans are infected from aerosols of rodent excreta, direct contact of broken skin or mucous membranes with infectious virus, or rodent bite. One hantavirus, Andes virus, is unique in that it is known to be transmitted from person-to-person. HFRS and HCPS, although primarily affecting kidneys and lungs, respectively, share a number of clinical features, such as capillary leakage, TNF-, and thrombocytopenia; notably, hemorrhages and alterations in renal function also occur in HCPS and cardiac and pulmonary involvement are not rare in HFRS. Of the four structural proteins, both in humoral and cellular immunity, the nucleocapsid protein appears to be the principal immunogen. Cytotoxic T-lymphocyte responses are seen in both HFRS and HCPS and may be important for both protective immunity and pathogenesis. Diagnosis is mainly based on detection of IgM antibodies although viral RNA (vRNA) may be readily, although not invariably, detected in blood, urine and saliva. For sero/genotyping neutralization tests/RNA sequencing are required. Formalin-inactivated vaccines have been widely used in China and Korea but not outside Asia. Hantaviruses are prime examples of emerging and re-emerging infections and, given the limited number of rodents and insectivores thus far studied, it is likely that many new hantaviruses will be detected in the near future.
APA, Harvard, Vancouver, ISO, and other styles
38

Snow, Kathryn, and Michael Levy. Harm Reduction in Prisons. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0017.

Full text
Abstract:
Interventions intended to minimize the harms of injecting drug use, particularly drug overdose and exposure to blood-borne viruses, have a long history of implementation in some community settings but are frequently unavailable in prisons. The denial of harm reduction measures to prisoners who inject drugs violates their right to non-discriminatory healthcare, as well as other facets of international human rights law. Evidence is available from several programs in diverse settings which demonstrates that it is possible to implement many harm reduction interventions in prisons, that such programs can reduce the risk of drug-related harms, and that concerns regarding unintended negative consequences of such programs are often unfounded. This chapter provides an overview of the key harm reduction measures relevant to the prison setting, with a particular focus on the provision of sterile injecting equipment to prisoners via needle and syringe exchange programs, and on the provision of the opioid antagonist naloxone as first-line treatment for opioid overdose to people while in prison and on leaving prison. The chapter reviews the legal basis for providing these and other harm reduction measures to prisoners, outlines the evidence that supports specific interventions, and highlights topics on which further research is needed.
APA, Harvard, Vancouver, ISO, and other styles
39

Moriuchi, Hiroyuki. Human T-cell Lymphotropic Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0010.

Full text
Abstract:
Human T-cell lymphotropic virus type 1 (HTLV-1), a human retrovirus that infects an estimated 10–20 million people worldwide, has endemic foci in Japan, West and Central Africa, the Caribbean, Central and South America, and Melanesia. Also, it is the etiological agent of a lymphoproliferative malignancy, adult T-cell leukemia/lymphoma (ATLL), as well as chronic inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 can be transmitted vertically, sexually, or by blood-borne transmission. ATLL occurs in approximately 5% of carriers who are infected during early childhood, and primary prevention is the only strategy likely to reduce this fatal disease. Children born to carrier mothers acquire the virus predominantly from breastfeeding. In endemic areas, mother-to-child transmission (MTCT) can be significantly reduced by screening pregnant women for the HTLV-1 antibody, followed by replacing breastfeeding with exclusive formula feeding. Indications for serological screening and recommendations for prevention of perinatal transmission are reviewed in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
40

Oraby, Tamer. Chapter 3 Xenotropic Murine Leukemia Virus-Related Virus as a Case Study: Using a Precautionary Risk Management Approach for Emerging Blood-Borne Pathogens in Canada. InTechOpen, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Milloy, M.-J. Injecting While Incarcerated. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0003.

Full text
Abstract:
Beginning approximately coincident with the advent of the global HIV pandemic, a growing number of qualitative and quantitative epidemiological studies have investigated the phenomenon of the injection of illicit psychoactive substances by individuals held within correctional settings. Empirical studies reveal that incarceration is a common experience for people who use illicit drugs, and injection while incarcerated (IWI) is an unintended if widespread consequence of the prohibition-based approach to regulating psychoactive drugs. Analyses of the spread of HIV, hepatitis C virus (HCV), and other blood-borne pathogens among injection drug users have identified IWI as an important risk factor. Although a number of evidence-based responses have been developed to mitigate the risks associated with IWI, they are unavailable to the vast majority of imprisoned people who use injection drugs.
APA, Harvard, Vancouver, ISO, and other styles
42

Swanepoel, R., and J. T. Paweska. Crimean-Congo haemorrhagic fever. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198570028.003.0033.

Full text
Abstract:
Crimean-Congo haemorrhagic fever (CCHF) is an acute disease of humans, caused by a tick-borne virus which is widely distributed in eastern Europe, Asia and Africa. Cattle, sheep and small mammals such as hares undergo inapparent or mild infection with transient viraemia, and serve as hosts from which the tick vectors of the virus can acquire infection. Despite serological evidence that there is widespread infection of livestock in nature, infection of humans is relatively uncommon. Humans acquire infection from tick bite, or from contact with infected blood or other tissues of livestock or human patients, and the disease is characterized by febrile illness with headache, malaise, myalgia, and a petechial rash, frequently followed by a haemorrhagic state with necrotic hepatitis. The mortality rate is variable but averages about approximately 30 per cent. Inactivated vaccine prepared from infected mouse brain was used for the protection of humans in eastern Europe and the former Soviet Union in the past, but the development of a modern vaccine is inhibited by limited potential demand. The voluminous literature on the disease has been the subject of several reviews from which the information presented here is drawn, except where indicated otherwise (Chumakov 1974; Hoogstraal 1979; 1981; Watts et al. 1989; Swanepoel 1994; 1995; Swanepoel and Burt, 2004; Burt and Swanepoel, 2005; Whitehouse 2004; Ergunol and Whitehouse 2007; Ergunol 2008).
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography